Align Technology (ALGN)
NASDAQ:ALGN
Want to see ALGN full AI Analyst Report?
ALGN Stock Chart & Stats
$190.07
-$2.61(-1.20%)
At close: 4:00 PM EST
$190.07
-$2.61(-1.20%)
Day’s Range― - ―
52-Week Range$122.00 - $208.31
Previous CloseN/A
Volume187.73K
Average Volume (3M)1.09M
Market Cap
$12.53B
Enterprise Value$11.55B
Total Cash (Recent Filing)$1.06B
Total Debt (Recent Filing)$83.42M
Price to Earnings (P/E)29.1
Beta1.36
Next Earnings
Jul 29, 2026EPS Estimate
2.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.97
Shares Outstanding71,618,126
10 Day Avg. Volume1,201,096
30 Day Avg. Volume1,091,181
Financial Highlights & Ratios
PEG Ratio51.80
Price to Book (P/B)2.80
Price to Sales (P/S)2.81
P/FCF Ratio23.08
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue2.82
Enterprise Value/Gross Profit4.17
Enterprise Value/Ebitda14.32
Forecast
1Y Price Target
$208.00Price Target Upside9.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)11.38
Revenue Forecast (FY)$4.18B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage (~0.03 debt/equity) and growing equity provide durable financial flexibility. This limits refinancing risk, supports ongoing R&D, capital expenditures and buybacks, and helps the company absorb cyclical demand swings without pressuring capital allocation.
High And Expanding MarginsSustained high gross margins and recent non-GAAP margin expansion reflect improved manufacturing throughput, lower refinement rates and better treatment predictability. Higher margins enhance cash generation potential and provide a buffer against cost inflation over the medium term.
Integrated Product Ecosystem & Commercial TractionA large iTero installed base, growing DSP adoption and financing programs create network effects that raise switching costs and drive case conversions. Recurring software/services and tighter clinic integration support sustainable cross-selling and higher lifetime value per customer.
Bears Say
Regional Imbalance & Uneven Revenue GrowthDependence on international growth to offset North America softness creates revenue concentration risk and less predictable top-line trajectory. Uneven multi-year growth reduces visibility for capacity planning and may require ongoing investment to sustain global expansion.
Systems & Services Underperformance And Mix ShiftA shift toward lower-priced PC-based scanners and leasing dampens ASPs and slows the growth of higher-margin recurring services. Continued mix pressure could limit margin upside from Systems & Services and make hardware revenue more cyclical and price-sensitive.
Input-Cost Exposure And Elevated Working CapitalSignificant resin/plastics exposure ties gross margins to oil/resin price swings, raising cost volatility risk. High receivables and ~97 DSO lock up cash, strain operating liquidity and reduce predictability of free cash flow despite strong headline cash balances.
Align Tech News
ALGN FAQ
What was Align Technology’s price range in the past 12 months?
Align Technology lowest stock price was $122.00 and its highest was $208.31 in the past 12 months.
What is Align Technology’s market cap?
Align Technology’s market cap is $12.53B.
When is Align Technology’s upcoming earnings report date?
Align Technology’s upcoming earnings report date is Jul 29, 2026 which is in 57 days.
How were Align Technology’s earnings last quarter?
Align Technology released its earnings results on Apr 29, 2026. The company reported $2.58 earnings per share for the quarter, beating the consensus estimate of $2.295 by $0.285.
Is Align Technology overvalued?
According to Wall Street analysts Align Technology’s price is currently Undervalued.
Does Align Technology pay dividends?
Align Technology does not currently pay dividends.
What is Align Technology’s EPS estimate?
Align Technology’s EPS estimate is 2.64.
How many shares outstanding does Align Technology have?
Align Technology has 71,618,126 shares outstanding.
What happened to Align Technology’s price movement after its last earnings report?
Align Technology reported an EPS of $2.58 in its last earnings report, beating expectations of $2.295. Following the earnings report the stock price went down -1.34%.
Which hedge fund is a major shareholder of Align Technology?
Currently, no hedge funds are holding shares in ALGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Align Tech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$208.00 (9.43% Upside)
$208.00 (9.43% Upside)
Blogger Sentiment
Neutral
ALGN Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
News Sentiment
Bullish
Bullish news 79%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.17%
12-Months-Change
Fundamentals
Return on Equity
10.70%
Trailing 12-Months
Asset Growth
3.46%
Trailing 12-Months
Company Description
Align Technology
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
ALGN Company Deck
ALGN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated strong operational and financial performance: record Clear Aligner volumes, broad international growth, margin expansion, EPS and cash generation, and traction for commercial and product initiatives (DSP, financing, iTero/exocad integration). Management reiterated full-year guidance while taking a prudent stance given geopolitical uncertainty and flagged near-term risks (North America softness, Systems & Services seasonality, higher OpEx and resin/freight exposure). On balance the positives — robust volume growth, improving margins, product/platform momentum and capital returns — outweigh the challenges, though the company remains cautious on macro risks.View all ALGN earnings summariesALGN Revenue Breakdown
80.43% Clear Aligner
19.57% Systems and Services
ALGN Stock 12 Month Forecast
Average Price Target
$208.00
▲(9.43% Upside)
Technical Analysis
Smith & Nephew Snats
―
Ufp Technologies
―
Zimmer Biomet Holdings
―
Globus Medical
―
Glaukos
―
Ownership Overview
0.75% Insiders
32.23% Mutual Funds
37.55% Other Institutional Investors
5.47% Public Companies and
Individual Investors